Neuralink's "Blindsight" device, developed by Elon Musk's company, aims to restore vision for blind individuals.

The regulatory approval is just the first phase of a long project, but Neuralink owner Elon Musk is already touting his brain ...

The program gives manufacturers better access to regulators and the ability to design more flexible clinical trials.

The device is a variant of Neuralink's brain implant technology, in this case designed to "enable even those who have lost both eyes" to see, according to owner Elon Musk. Separately, progress is ...

Developing advanced drug screening tools is crucial for the advancement of personalized medicine and the creation of more effective treatments. One organ receiving particular attention in this area is ...

"It's an important breakthrough which means customers no longer have to spray twice or more to achieve the right thickness for providing high dielectric strength." In addition to production ...

This modification improves the stability, sensitivity and reproducibility of cortisol detection in point-of-care devices.” A) The research team use iridium oxide to coat the reference electrode and ...

The US Food and Drug Administration (FDA) granted Abbott Breakthrough Device designation to explore use of DBS for TRD under its Breakthrough Devices Program, which expedites the review of innovative ...

When you buy through links on our articles, Future and its syndication partners may earn a commission. Apple has been slowly making more and more components of its devices in house; a new report ...

Apple has been slowly making more and more components of its devices in house; a new report claims that batteries could soon join the ranks of parts that Apple develops on its own. And those ...

Summary. In 2008 Abbott introduced a revolutionary new device, FreeStyle Navigator, designed to improve the lives of the world’s more than 500 million diabetes patients by offering continuous ...